WMG Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-440
Closed -$213K 196
2025
Q3
$213K Buy
+440
New +$205K 0.07% 194
2025
Q2
Sell
-452
Closed -$225K 195
2025
Q1
$225K Buy
452
+2
+0.4% +$1.08K 0.1% 154
2024
Q4
$234K Buy
450
+10
+2% +$5.5K 0.1% 143
2024
Q3
$272K Sell
440
-49
-10% -$29K 0.12% 124
2024
Q2
$270K Buy
489
+70
+17% +$40.1K 0.14% 110
2024
Q1
$244K Buy
+419
New +$235K 0.14% 116
2023
Q3
Sell
-402
Closed -$210K 120
2023
Q2
$210K Buy
402
+33
+9% +$17.8K 0.15% 112
2023
Q1
$256K Buy
+369
New +$208K 0.21% 83
2022
Q3
Sell
-406
Closed -$221K 153
2022
Q2
$221K Hold
406
0.19% 123
2022
Q1
$239K Buy
406
+77
+23% +$44.2K 0.18% 140
2021
Q4
$220K Buy
+329
New +$205K 0.17% 158

Other funds holding TMO

WMG Financial Advisors's TMO Position: Q4 2025 in Review

WMG Financial Advisors sold out of Thermo Fisher Scientific (TMO) in Q4 2025, closing a stake of 440 shares — an estimated $213K sold.

WMG Financial Advisors first reported a position in TMO in Q4 2021 and held it in 11 quarters. The position peaked at $272K in Q3 2024. 2,700 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

  • WMG Financial Advisors reported no remaining Thermo Fisher Scientific position as of Q4 2025 after selling out during the quarter.
  • WMG Financial Advisors sold 440 Thermo Fisher Scientific shares in Q4 2025, an estimated $213K.
  • WMG Financial Advisors first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 11 quarters.
  • WMG Financial Advisors's Thermo Fisher Scientific position peaked at $272K in Q3 2024.
  • 2,700 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on WMG Financial Advisors's 13F filing for Q4 2025, filed 28 Jan 2026.